Medicamen Biotech Limited - PE Ratio

The PE Ratio as of October 2026 (TTM) for Medicamen Biotech Limited (MEDICAMEQ.BO) is 40.48

According to Medicamen Biotech Limited’s latest financial reports and current stock price. The company's current PE Ratio is 40.48. This represents a change of 0.53% compared to the average of 40.27 of the last 4 quarters.

Medicamen Biotech Limited (MEDICAMEQ.BO) Historical PE Ratio (quarterly & annually)

How has MEDICAMEQ.BO PE Ratio performed in the past?

The mean historical PE Ratio of Medicamen Biotech Limited over the last ten years is 60.68. The current 40.48 PE Ratio has changed 6.57% with respect to the historical average. Over the past ten years (40 quarters), MEDICAMEQ.BO's PE Ratio was at its highest in in the September 2023 quarter at 136.58. The PE Ratio was at its lowest in in the March 2026 quarter at 17.02.

Medicamen Biotech Limited (MEDICAMEQ.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medicamen Biotech Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Medicamen Biotech Limited (MEDICAMEQ.BO) Average PE Ratio

How has MEDICAMEQ.BO PE Ratio performed in the past?

The current PE Ratio of Medicamen Biotech Limited (MEDICAMEQ.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Medicamen Biotech Limited (MEDICAMEQ.BO) PE Ratio vs. Peers

How is MEDICAMEQ.BO’s PE Ratio compared to its peers?

Medicamen Biotech Limited’s PE Ratio is greater than Albert David Limited (19.78), greater than Medico Remedies Limited (13.29), greater than Kilitch Drugs (India) Limited (27.08), greater than Medico Remedies Limited (13.29), greater than Venus Remedies Limited (18.64), greater than Venus Remedies Limited (18.64), less than ZIM Laboratories Limited (185.50), less than ZIM Laboratories Limited (185.50), greater than Kilitch Drugs (India) Limited (27.08), less than Bafna Pharmaceuticals Limited (129.59),

Build a custom stock screener for Medicamen Biotech Limited (MEDICAMEQ.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medicamen Biotech Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medicamen Biotech Limited (MEDICAMEQ.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medicamen Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.